{"entity":{"id":"nct07802418","kind":"trial","name":"Molecularly Tailored Therapy in Advanced Pancreatic Cancer","aka":["TAILOR-PANC"],"tldr":"A phase 2 trial in pancreatic cancer, run by Herlev Hospital, not yet recruiting.","summary":"Molecularly Tailored Therapy in Advanced Pancreatic Cancer is a phase 2, randomised interventional study registered as NCT07802418 by Herlev Hospital, with a registry enrolment figure of 1200 participants, started 2026-10 and due to reach its primary completion in 2031-06. Interventions recorded: Arm 1: Molecularly Tailored Therapy; Arms 2: Standard-of-Care Therapy; Arm 3: Standard-of-Care Observational Cohort. Conditions listed: Pancreatic Cancer. Primary outcome: Progression-Free Survival in Randomized Participants. Sites: Denmark. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07802418","url":"https://clinicaltrials.gov/study/NCT07802418"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["metastatic-pdac"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07802418","phase":"2","setting":"TAILOR-PANC: Molecularly Tailored Therapy Versus Standard Care in Advanced Pancreatic Cancer (DPCG-02)","sponsor":"Herlev Hospital","enrolled":1200,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07802418/","neighbours":{"cancer":[{"id":"metastatic-pdac","kind":"cancer","name":"Metastatic pancreatic ductal adenocarcinoma","route":"/cancers/metastatic-pdac/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}